MORF: The acquisition of Morphic Holding, Inc. (MORF) by Eli Lilly and Company (LLY) for a closing value of $3.2 billion. As per the terms of the agreement, Lilly will commence a tender offer to acquire all outstanding shares of Morphic for a purchase price of $57 per share in cash.
OLK: UK CMA cleared the anticipated acquisition of Olink Holding (OLK) by Thermo Fisher Scientific (TMO).
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok